Testing effectiveness (Phase 2)Study completedNCT00971932
What this trial is testing
Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Merck KGaA, Darmstadt, Germany 33